Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.96 USD | -0.93% | +5.01% | -6.87% |
May. 21 | JPMorgan Starts Structure Therapeutics With Overweight Rating | MT |
May. 09 | Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 22.22M | Capitalization | 1.79B |
---|---|---|---|---|---|
Net income 2024 * | -134M | Net income 2025 * | -157M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 156M | EV / Sales 2025 * | 73.4 x |
P/E ratio 2024 * |
-43.1
x | P/E ratio 2025 * |
-34.5
x | Employees | 93 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.06% |
1 day | +5.33% | ||
1 week | +6.80% | ||
Current month | -2.84% | ||
1 month | +6.18% | ||
3 months | -5.41% | ||
6 months | -25.40% | ||
Current year | -5.99% |
Managers | Title | Age | Since |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 19-01-31 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 19-01-31 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 22-03-28 |
Ted Love
BRD | Director/Board Member | 65 | 23-08-02 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 22-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 37.96 | -0.94% | 260 958 |
24-05-23 | 38.32 | +5.33% | 767,947 |
24-05-22 | 36.38 | +1.59% | 827,704 |
24-05-21 | 35.81 | +0.08% | 535,293 |
24-05-20 | 35.78 | -1.02% | 318,421 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.99% | 1.79B | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.14% | 21.58B | |
-9.21% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- GPCR Stock